In the assessment of 12-month price targets, analysts unveil insights for Globus Medical, presenting an average target of $90 ...

Globus Medical (NYSE:GMED) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the ...